Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study - Wikidata - wikimedia - TriplyDB

Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study

Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study

http://www.wikidata.org/entity/Q30356815

about

The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer.

P2860

Q36764919-26489971-4AD3-460E-B7BF-7687AFD87251

P2860

Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study

http://www.wikidata.org/entity/Q30356815

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Assessing the prognostic role ...... necologic Oncology Group study

@ast

Assessing the prognostic role ...... necologic Oncology Group study

@en

type

label

Assessing the prognostic role ...... necologic Oncology Group study

@ast

Assessing the prognostic role ...... necologic Oncology Group study

@en

prefLabel

Assessing the prognostic role ...... necologic Oncology Group study

@ast

Assessing the prognostic role ...... necologic Oncology Group study

@en

P1433

Q30356815-2199EC7B-B7BC-4516-965A-6D5BF7EAB793

P1476

Q30356815-585FA8A2-0142-4C97-8676-AE8A14710AF5

P2093

Q30356815-17426A60-8281-4544-9DFB-DC1788079CFD

Q30356815-27457A6E-DED1-4772-96EE-F35BD4EFF352

Q30356815-3B1868F1-2D01-47D1-9CD3-EFCB91680C79

Q30356815-3FD64952-4622-4EA1-B120-61939CAC1BEE

Q30356815-459278D4-10F1-4C08-9F80-D2676BCC3778

Q30356815-54990DBA-7799-482D-A11A-998280406A38

Q30356815-5A6FDAEA-AB57-46FA-8C0A-6BE29E83813B

Q30356815-5BEC82E5-E7C8-425B-AD7E-A9CE6F00D775

Q30356815-9915C802-9B81-4E14-98FC-A964F2688A54

Q30356815-B38DB017-19DC-45BE-BBD9-113652A42C88

P2860

Q30356815-0B670306-9342-4B80-9C6F-5FDB88BD0D2D

Q30356815-0E8D995E-F0FA-4254-AF70-D018B8D17D12

Q30356815-2621D3BE-ED35-4B55-9207-4DE1960B0D9C

Q30356815-2A23FA0C-2BE8-4092-828F-882E277E7520

Q30356815-35195589-44C6-4FAD-B296-D7FE3A73C67A

Q30356815-57794EFA-91B1-4AA2-BB65-4409CDF2924C

Q30356815-7F0C189D-1EFD-40C0-9C7B-8C36A96CBB31

Q30356815-7F65FF54-8B89-49AF-869C-CBF2881634EB

Q30356815-90FC4AC4-CB37-40C4-B9B0-7AA31153F012

Q30356815-C395428A-2BA6-4E34-809A-61C5C72DFF89

P304

Q30356815-FE164C46-B558-47E4-BA91-92EC5581B76D

P31

Q30356815-E7E551E0-D71B-45DD-8D42-9BDBFC390EB0

P356

Q30356815-EEDED762-72ED-4E42-9A1F-78440BD3B643

P407

Q30356815-BC296201-A28A-4B39-AD0C-8D45206956EB

P433

Q30356815-C7138310-FDC2-4B13-B587-926105A783E9

P478

Q30356815-96EF9C01-C175-47C7-813B-69954D549DB9

P50

Q30356815-C1B4110F-AEE4-44E9-A013-DBE3D7FCE74A

P577

Q30356815-2E70F131-92FC-43E8-9175-59F0B6F0E800

P698

Q30356815-76A76ED2-7DB5-4691-A684-ADAB899ACF18

P932

Q30356815-CC383AC6-7506-4027-A844-2546240FF7CF

P356

J.YGYNO.2015.06.038

P1433

Gynecologic Oncology

P1476

Assessing the prognostic role ...... necologic Oncology Group study

@en

P2093

David Mutch

http://www.w3.org/2001/XMLSchema#string

Heather A Lankes

http://www.w3.org/2001/XMLSchema#string

Israel Zighelboim

http://www.w3.org/2001/XMLSchema#string

Kathleen Moore

http://www.w3.org/2001/XMLSchema#string

Katina Robison

http://www.w3.org/2001/XMLSchema#string

Kian Behbakht

http://www.w3.org/2001/XMLSchema#string

Michael Pearl

http://www.w3.org/2001/XMLSchema#string

Nilsa C Ramirez

http://www.w3.org/2001/XMLSchema#string

Paul Goodfellow

http://www.w3.org/2001/XMLSchema#string

Rahel G Ghebre

http://www.w3.org/2001/XMLSchema#string

P2860

A role for ATR in the DNA damage-induced phosphorylation of p53

cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein

ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.

Cancer statistics, 2014

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

Integrated genomic characterization of endometrial carcinoma

Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.

Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.

Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.

Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma

P304

614-619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2015.06.038

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26144601

http://www.w3.org/2001/XMLSchema#string

P932

4556563

http://www.w3.org/2001/XMLSchema#string